Coalition to Accelerate Access to Long-Acting PrEP

The Coalition to Accelerate Access to Long-Acting PrEP is an initiative that brings together leading donors, agencies, and advocates to ensure an accelerated, equitable, sustainable and collaborative approach to making longer-acting PrEP options accessible as quickly and as equitably as possible. The Coalition is convened by Unitaid, WHO, UNAIDS, Global Fund and PEPFAR, with AVAC as the Secretariat.

Mentor Application Form

Download the application here or click the link on the right of this page.

The Advocacy Navigator is an AVAC initiative combining training and mentorship to young and emerging advocates in the field of HIV prevention advocacy. Mentors will serve as advisors to the Navigators, supporting them as they go through their coursework and while they design and implement their Community Advocacy Project. More information at www.avac.org/navigator.

Advocacy Navigator Call For Applications

Download the application here or click the link to the right of this page. Please note, you will need to download and fill the application on a laptop or desktop computer. It is not possible to use a mobile phone to fill out the application.

The Advocacy Navigator program is open to any individual interested in HIV prevention advocacy currently residing in Southern or Eastern Africa. This is a six month program with a three to four hour weekly time commitment. AVAC will provide online coursework in HIV prevention and advocacy and match participants with a mentor. Participants will receive a small project grant. More information at www.avac.org/navigator.

Advocacy Navigator Call for Mentor Applications

The Advocacy Navigator program is open to any AVAC Alumni interested in serving as a mentor to emerging HIV prevention advocates currently residing in Southern or Eastern Africa. This is a six month program in HIV prevention advocacy. The mentor time commitment should be approximately one to two hours per week with the Navigator (program participant. A modest communication and mentorship stipend is available. More information at www.avac.org/navigator.

A Call to Greater Action

Mobilizing People of Faith to Build Networks to Protect Human Rights and Overcome Homophobia

A call to action for faith leaders from across the region to join in solidarity in defense of human rights and evidence-based HIV prevention, including for vulnerable populations.

ICASA 2023 Prevention Roadmap

View the ICASA roadmap for details on sessions that help to:

  • Accelerate and expand access to proven prevention options that people want and need. 
  • Dismantle the structural barriers to health faced by key populations. 
  • Intensify demands for robust domestic and global funding for health. 
  • Integrate HIV services with sexual and reproductive health. 
  • And much more. 

For all the latest from the conference, visit avac.org/icasa2023.

From the Lab to the Jab

A series of advocate guides to the latest in vaccine R&D

From the Lab to Jab are a series of briefs to learn the latest in vaccine R&D for HIV, COVID-19, TB and other global public health threats. Access them all here and stay tuned for a related webinar in early 2024. Watch this space or sign up for our email newsletter.

Community Manifesto for HIV Long-Acting Injectable PrEP in Europe

This document stems from a March 2023 consensus meeting in Paris involving regional and international HIV prevention organizations and activists. Four main pillars were identified to promote new PrEP technologies and expand access to long-Acting injectable PrEP in Europe. These pillars should be implemented simultaneously and also aim to broaden PrEP accessibility beyond LA-CAB.

Coalition to Accelerate & Support Prevention Research (CASPR)

Project Brief

The Coalition to Accelerate & Support Prevention Research (CASPR) project focuses on developing and sustaining an Africa-centered network dedicated to accelerating biomedical HIV prevention research, and advancing equitable access to proven HIV prevention products.

Phase 1 mRNA HIV Vaccine Trials

A breakdown of current HIV mRNA trials and a primer on the basics of mRNA technology.